Enhancing therapeutic efficacy through designed aggregation of nanoparticles
Source abstract
Abstract
Particle size is a key determinant of biological performance of sub-micron size delivery systems. Previous studies investigating the effect of particle size have primarily focused on well-dispersed nanoparticles. However, inorganic nanoparticles are prone to aggregation in biological environments. In our studies, we examined the consequence of aggregation on superparamagnetic iron oxide (SPIO) nanoparticle-induced magnetic hyperthermia. Here we show that the extent and mechanism of hyperthermia-induced cell kill is highly dependent on the aggregation state of SPIO nanoparticles. Well-dispersed nanoparticles induced apoptosis, similar to that observed with conventional hyperthermia. Sub-micron size aggregates, on the other hand, induced temperature-dependent autophagy through generation of oxidative stress. Micron size aggregates caused rapid membrane damage, resulting in acute cell kill. Overall, this work highlights the potential for developing highly effective anticancer therapeutics through designed aggregation of nano delivery systems.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanopore and Nanochannel Transport Studies · Autophagy in Disease and Therapy
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (53)
Show source-provided references
1. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
2. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel10.1158/1078-0432.CCR-05-1634 ↗
3. Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns10.1158/0008-5472.CAN-12-1527 ↗
4. Mediating tumor targeting efficiency of nanoparticles through design10.1021/nl900031y ↗
5. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size
6. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags10.1038/nbt1377 ↗
7. Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging10.1021/ja061529k ↗
8. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
9. Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates10.1002/smll.200800199 ↗
10. Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles10.1016/j.biomaterials.2008.09.044 ↗
11. Interactions between sub-10-nm iron and cerium oxide nanoparticles and 3T3 fibroblasts: the role of the coating and aggregation state10.1088/0957-4484/21/14/145103 ↗
12. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts10.1073/pnas.0805135105 ↗
13. Application of magnetite ferrofluids for hyperthermia10.1016/S0304-8853(99)00145-6 ↗
14. Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles10.1016/S0304-8853(99)00088-8 ↗
15. Physical limits of hyperthermia using magnetite fine particles10.1109/20.718537 ↗
16. Heating magnetic fluid with alternating magnetic field10.1016/S0304-8853(02)00706-0 ↗
17. Focused RF hyperthermia using magnetic fluids10.1118/1.3106343 ↗
18. Localised heating of tumours utilising injectable magnetic nanoparticles for hyperthermia cancer therapy10.1049/iet-nbt.2008.0013 ↗
19. Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors10.1021/nn101427t ↗
20. Spectrophotometric determination of iron with orthophenanthroline10.1016/0026-265X(70)90101-3 ↗
21. Magnetic nanoparticle biodistribution following intratumoral administration10.1088/0957-4484/22/34/345101 ↗
22. Hyperthermia triggers apoptosis and affects cell adhesiveness in human neuroblastoma cells
23. Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles
24. Apoptosis and perturbation of cell cycle progression in an acidic environment after hyperthermia
25. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE10.1038/371346a0 ↗
26. Autophagic cell death and its execution by lysosomal cathepsins10.1679/aohc.64.233 ↗
27. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration10.1186/1478-811X-8-31 ↗
28. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing10.1093/emboj/19.21.5720 ↗
29. Another way to die: autophagic programmed cell death10.1038/sj.cdd.4401777 ↗
30. Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells10.1093/toxsci/kfp101 ↗
31. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells10.1038/sj.cdd.4402233 ↗
32. Subapoptogenic oxidative stress strongly increases the activity of the glycolytic key enzyme glyceraldehyde 3-phosphate dehydrogenase10.1111/j.1749-6632.2009.04723.x ↗
33. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation10.1016/j.cell.2007.03.045 ↗
34. Necrosis: a specific form of programmed cell death?10.1016/S0014-4827(02)00027-7 ↗
35. Magnetoporation and magnetolysis of cancer cells via carbon nanotubes induced by rotating magnetic fields10.1021/nl301928z ↗
36. Heat shock protein 70 (HSP70) prolongs survival in rats exposed to hyperthermia10.1046/j.1365-2362.1999.00503.x ↗
37. Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles10.1007/s00262-002-0335-x ↗
38. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance10.1016/j.jconrel.2009.01.021 ↗
39. Apoptotic and necrotic blebs in epithelial cells display similar neck diameters but different kinase dependency10.1038/sj.cdd.4401236 ↗
40. Remote control of ion channels and neurons through magnetic-field heating of nanoparticles10.1038/nnano.2010.125 ↗
41. Monitoring iron oxide nanoparticle surface temperature in an alternating magnetic field using thermoresponsive fluorescent polymers10.1063/1.3680532 ↗
42. Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies10.1111/j.1478-3231.2008.01915.x ↗
43. Stimulation of anti-tumor immunity by photodynamic therapy10.1586/eci.10.81 ↗
44. Natural killer cell-mediated ablation of metastatic liver tumors by hydrodynamic injection of IFNα gene to mice10.1002/ijc.22152 ↗
45. Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake10.1016/0261-5614(92)90006-C ↗
46. Nanomedicine in pulmonary delivery10.2147/IJN.S4937 ↗
47. Inhaling medicines: delivering drugs to the body through the lungs10.1038/nrd2153 ↗
48. Overexpression of the mu-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis10.1097/ALN.0b013e31824babe2 ↗
49. Inhaled chemotherapy in lung cancer: future concept of nanomedicine10.2147/IJN.S29997 ↗
50. Inhalation adjuvant therapy for lung cancer10.1089/jamp.2009.0787 ↗
51. MRI-guided interventions for the treatment of prostate cancer10.2214/AJR.12.8725 ↗
52. Radiologically-guided thermal ablation of renal tumours
53. Image-guided ablative therapies for lung cancer10.1016/j.rcl.2012.06.004 ↗